ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRY ARS PHARMACEUTICALS INC

盘前交易 02-18 08:48:26 EST

9.38

+0.53

+5.99%

盘前9.52

+0.14+1.49%

08:21 EST

最高9.52	最低8.66	成交量88.62万
今开8.66	昨收8.85	日振幅9.72%
总市值9.27亿	流通市值5.18亿	总股本9,885万
成交额823.42万	换手率1.60%	流通股本5,527万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":9.38,"timestamp":1771362000000,"preClose":8.85,"halted":0,"volume":886195,"hourTrading":{"tag":"盘前","latestPrice":9.52,"preClose":9.38,"latestTime":"08:21 EST","volume":19,"amount":182.949993,"timestamp":1771420906850,"change":0.14,"changeRate":0.014925,"amplitude":0.02452},"delay":0,"changeRate":0.05988700564971765,"floatShares":55270496,"shares":98848611,"eps":-0.81541,"marketStatus":"盘前交易","change":0.53,"latestTime":"02-18 08:48:26 EST","open":8.66,"high":9.52,"low":8.66,"amount":8234178.32395,"amplitude":0.097175,"askPrice":10.33,"askSize":137,"bidPrice":9.12,"bidSize":125,"shortable":3,"etf":0,"ttmEps":-0.81541,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771425000000},"marketStatusCode":1,"adr":0,"listingDate":1607058000000,"exchange":"NASDAQ","adjPreClose":9.38,"preHourTrading":{"tag":"盘前","latestPrice":9.52,"preClose":9.38,"latestTime":"08:21 EST","volume":19,"amount":182.949993,"timestamp":1771420906850,"change":0.14,"changeRate":0.014925,"amplitude":0.02452},"postHourTrading":{"tag":"盘后","latestPrice":9.5,"preClose":9.38,"latestTime":"19:34 EST","volume":30152,"amount":283479.1633,"timestamp":1771374895701,"change":0.12,"changeRate":0.012793,"amplitude":0.031567},"volumeRatio":0.71155562568263,"impliedVol":1.2044,"impliedVolPercentile":0.872},"requestUrl":"/m/hq/s/SPRY","defaultTab":"news","newsList":[{"id":"2609219534","title":"Ars Pharmaceuticals, Inc.盘中异动 临近收盘快速跳水5.03%报9.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609219534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609219534?lang=zh_cn&edition=full","pubTime":"2026-02-06 04:53","pubTimestamp":1770324815,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日04时53分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.03%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。其相关个股中，Bone Biologics Corp C/Wts 13/10/2026 、Liminatus Pharma, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Aim Immunotech Inc.、Transcode Therapeutics, Inc.、Propanc Biopharma, Inc.较为活跃，换手率分别为2057.86%、1263.43%、275.36%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Bone Biologics Corp C/Wts 13/10/2026 、Aim Immunotech Inc.，振幅分别为106.67%、70.70%、68.24%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206045335a4817dca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206045335a4817dca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1186197538","title":"Eurneffy® 1毫克（肾上腺素鼻喷雾剂）获欧盟推荐批准，用于体重≥15公斤至＜30公斤儿童1型过敏反应（包括过敏性休克）的紧急治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1186197538","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186197538?lang=zh_cn&edition=full","pubTime":"2026-02-02 21:03","pubTimestamp":1770037400,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc. 宣布，其产品Eurneffy® 1毫克（肾上腺素鼻喷雾剂）已获得欧盟人用药品委员会（CHMP）的积极意见，建议批准该药物用于体重在15公斤至30公斤以下（含15公斤，不含30公斤）的儿童患者，紧急治疗1型过敏反应，其中包括可能危及生命的过敏性休克。这一推荐标志着在儿童严重过敏应急治疗领域取得了一项重要进展，为小体重患儿提供了一种潜在的非注射给药选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2603683635","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603683635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603683635?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:45","pubTimestamp":1768229110,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时45分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.24%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Day One Biopharmaceuticals, Inc.、Forte Biosciences, Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为538.92%、111.61%、48.15%，振幅较大的相关个股有Pyxis Oncology, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Geovax Labs, Inc.，振幅分别为26.42%、25.56%、24.64%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222451097a17707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222451097a17707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1128364104","title":"ARS Pharmaceuticals将获400万美元监管里程碑付款，并有望获得高达8000万美元销售里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1128364104","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128364104?lang=zh_cn&edition=full","pubTime":"2025-12-29 21:04","pubTimestamp":1767013484,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals（纳斯达克代码：SPRY）近日宣布，公司将获得一笔400万美元的监管里程碑付款。此外，根据相关协议条款，该公司还有资格获得最高达8000万美元的销售里程碑款项。这一进展标志着公司在商业化进程中迈出重要一步，也为未来业绩增长提供了有力支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"1199872730","title":"Neffy®（肾上腺素鼻喷雾剂）在华获批，成为首个且唯一可用于社区治疗的过敏反应（严重过敏）急救产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1199872730","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199872730?lang=zh_cn&edition=full","pubTime":"2025-12-29 21:03","pubTimestamp":1767013385,"startTime":"0","endTime":"0","summary":"肾上腺素鼻喷雾剂Neffy®已正式获得中国监管部门的批准，该产品是首个且目前唯一获批用于社区场景、治疗过敏反应（严重过敏）的肾上腺素制剂。这一批准为患者提供了更为便捷和及时的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"1133887171","title":"异动解读 | ARS制药季度业绩亮眼，股价盘前飙升7.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133887171","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133887171?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:38","pubTimestamp":1762778319,"startTime":"0","endTime":"0","summary":"周一盘前，ARS制药（股票代码：SPRY）股价大幅上涨7.34%，引起投资者广泛关注。\n\n这波涨势似乎源于公司刚刚发布的2025年第三季度财务报告。ARS制药在盘前公布了其最新季度业绩以及旗下产品Neffy®的最新进展，这份报告显然给市场带来了积极信号。\n\n尽管具体财务数据尚未完全披露，但投资者对这份报告反应热烈，推动股价在开盘前显著上涨。分析人士认为，这可能意味着公司的业绩超出市场预期，特别是Neffy®产品线的表现可能相当出色。随着交易日的开始，我们预计会看到更多关于ARS制药财报的详细分析和市场反应。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SPRY"],"gpt_icon":0},{"id":"1112333909","title":"ARS Pharmaceuticals公布2025年第三季度财务结果及Neffy®的亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=1112333909","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112333909?lang=zh_cn&edition=full","pubTime":"2025-11-10 19:02","pubTimestamp":1762772540,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals公布2025年第三季度财务结果及Neffy®的亮点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2581317590","title":"Ars Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581317590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581317590?lang=zh_cn&edition=full","pubTime":"2025-11-06 03:43","pubTimestamp":1762371834,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日03时43分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.05%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Sonnet Biotherapeutics Holdings, Inc.、Enveric Biosciences, Inc.涨幅较大，Lunai Bioworks Inc.、Immuron Limited、Metavia Inc.较为活跃，换手率分别为628.82%、88.40%、79.44%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Ethzilla Corporation C/Wts 06/11/2025、Lunai Bioworks Inc.，振幅分别为84.66%、75.37%、74.26%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106034355a48b58d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106034355a48b58d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"1108658851","title":"ARS Pharma推出GET Neffy®以改善重度过敏反应患者对Neffy（肾上腺素鼻喷雾剂）的获取","url":"https://stock-news.laohu8.com/highlight/detail?id=1108658851","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108658851?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:01","pubTimestamp":1762261310,"startTime":"0","endTime":"0","summary":"ARS Pharma推出GET Neffy®，旨在为重度过敏反应患者改善对Neffy（肾上腺素鼻喷雾剂）的获取。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2578350371","title":"Ars Pharmaceuticals, Inc.盘中异动 临近收盘快速下跌5.08%报9.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578350371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578350371?lang=zh_cn&edition=full","pubTime":"2025-10-25 03:32","pubTimestamp":1761334366,"startTime":"0","endTime":"0","summary":"北京时间2025年10月25日03时32分，Ars Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.08%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Inhibrx Biosciences, Inc.、Genenta Science Spa、Neuphoria Therapeutics Inc.涨幅较大，Neuphoria Therapeutics Inc.、Theriva Biologics, Inc.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为3473.15%、2881.41%、2487.19%，振幅较大的相关个股有Theriva Biologics, Inc.、Genenta Science Spa、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.04%、133.75%、84.64%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251025033246a6cc8e82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251025033246a6cc8e82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2574772432","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574772432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574772432?lang=zh_cn&edition=full","pubTime":"2025-10-10 23:03","pubTimestamp":1760108595,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日23时03分，Ars Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.01%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102303159726ba39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102303159726ba39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1170206591","title":"ARS Pharmaceuticals就Neffy®（肾上腺素鼻喷剂）相关专利获得欧洲专利局有利决定","url":"https://stock-news.laohu8.com/highlight/detail?id=1170206591","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170206591?lang=zh_cn&edition=full","pubTime":"2025-10-08 20:04","pubTimestamp":1759925054,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals就其Neffy®（肾上腺素鼻喷剂）相关专利获得了欧洲专利局的有利决定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2572837839","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.45%报10.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572837839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572837839?lang=zh_cn&edition=full","pubTime":"2025-09-30 21:33","pubTimestamp":1759239239,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日21时33分，Ars Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.45%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Scisparc Ltd.、Anaptysbio, Inc.、Nanobiotix涨幅较大，Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为898.49%、248.26%、247.74%，振幅较大的相关个股有Scisparc Ltd.、Silexion Therapeutics Corp、Barinthus Biotherapeutics Plc，振幅分别为19.51%、14.16%、11.49%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930213359971a6979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930213359971a6979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"1146721721","title":"ARS Pharmaceuticals获得高达2.5亿美元贷款额度，与Ra Capital Management和Omers Life Sciences合作加速Neffy®在美国的商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1146721721","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146721721?lang=zh_cn&edition=full","pubTime":"2025-09-30 04:06","pubTimestamp":1759176388,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals获得高达2.5亿美元贷款额度，与Ra Capital Management和Omers Life Sciences合作加速Neffy®在美国的商业化","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"1132385495","title":"Neffy®（肾上腺素鼻喷剂）在日本获批，成为首个且唯一的无针头过敏反应（过敏性休克）紧急治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1132385495","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132385495?lang=zh_cn&edition=full","pubTime":"2025-09-19 20:01","pubTimestamp":1758283315,"startTime":"0","endTime":"0","summary":"Neffy®（肾上腺素鼻喷剂）在日本获批，成为首个且唯一的无针头过敏反应（过敏性休克）紧急治疗药物","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2568452409","title":"Ars Pharmaceuticals, Inc.盘中异动 临近收盘急速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568452409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568452409?lang=zh_cn&edition=full","pubTime":"2025-09-17 03:41","pubTimestamp":1758051693,"startTime":"0","endTime":"0","summary":"北京时间2025年09月17日03时41分，Ars Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.02%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Kalaris Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、冠科美博涨幅较大，Aptevo Therapeutics Inc.、Adaptimmune Therapeutics Plc、Silo Pharma, Inc.较为活跃，换手率分别为3424.63%、174.64%、119.10%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Jasper Therapeutics Inc C/Wts 24/09/2026 ，振幅分别为89.58%、76.00%、44.27%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250917034135a4ca1843&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250917034135a4ca1843&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2517461243","title":"ARS Pharmaceuticals(SPRY.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517461243","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517461243?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:25","pubTimestamp":1741386325,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals(SPRY.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价30.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08062548605319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SPRY"],"gpt_icon":0},{"id":"2517398688","title":"Ars Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.01%报10.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517398688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517398688?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:18","pubTimestamp":1741119485,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时18分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.01%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041805abe85197&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041805abe85197&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2514385185","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.57%报10.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385185?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:31","pubTimestamp":1740666704,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分，Ars Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.57%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为405.81%、90.91%、50.39%，振幅较大的相关个股有Pds Biotechnology Corporation、天演药业、Syros Pharmaceuticals, Inc.，振幅分别为11.69%、10.10%、10.09%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223144abdf6e9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223144abdf6e9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2513377332","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大跌5.16%报10.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513377332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513377332?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:31","pubTimestamp":1740411117,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时31分，Ars Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.16%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为205.96%、86.70%、27.91%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233158a25222ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233158a25222ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ars-pharma.com","stockEarnings":[{"period":"1week","weight":-0.0544},{"period":"1month","weight":-0.1176},{"period":"3month","weight":0.323},{"period":"6month","weight":-0.3692},{"period":"1year","weight":-0.2196},{"period":"ytd","weight":-0.1948}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0127},{"period":"3month","weight":0.0305},{"period":"6month","weight":0.0744},{"period":"1year","weight":0.12},{"period":"ytd","weight":0.0014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ARS Pharmaceuticals, Inc.于2016年1月4日根据特拉华州法律成立。该公司是一家生物制药公司，专注于开发新型、可能是一流的候选产品，neffy用于I型过敏反应的紧急治疗，包括过敏反应。neffy是一种肾上腺素的专有组合物，具有一种名为Intravail的创新吸收增强剂，允许neffy以小剂量、易于携带、易于使用、快速给药和可靠的鼻喷雾剂提供注射般的肾上腺素吸收。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.048654},{"month":2,"riseRate":0.5,"avgChangeRate":0.061532},{"month":3,"riseRate":0.4,"avgChangeRate":-0.024933},{"month":4,"riseRate":0.2,"avgChangeRate":-0.083829},{"month":5,"riseRate":0.8,"avgChangeRate":0.021109},{"month":6,"riseRate":0.6,"avgChangeRate":0.093442},{"month":7,"riseRate":0.8,"avgChangeRate":0.11695},{"month":8,"riseRate":0.4,"avgChangeRate":-0.080641},{"month":9,"riseRate":0.2,"avgChangeRate":-0.212128},{"month":10,"riseRate":0.4,"avgChangeRate":-0.021216},{"month":11,"riseRate":0.4,"avgChangeRate":0.043601},{"month":12,"riseRate":0.6,"avgChangeRate":0.080317}],"exchange":"NASDAQ","name":"ARS PHARMACEUTICALS INC","nameEN":"ARS PHARMACEUTICALS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ARS PHARMACEUTICALS INC(SPRY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ARS PHARMACEUTICALS INC,SPRY,ARS PHARMACEUTICALS INC股票,ARS PHARMACEUTICALS INC股票老虎,ARS PHARMACEUTICALS INC股票老虎国际,ARS PHARMACEUTICALS INC行情,ARS PHARMACEUTICALS INC股票行情,ARS PHARMACEUTICALS INC股价,ARS PHARMACEUTICALS INC股市,ARS PHARMACEUTICALS INC股票价格,ARS PHARMACEUTICALS INC股票交易,ARS PHARMACEUTICALS INC股票购买,ARS PHARMACEUTICALS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ARS PHARMACEUTICALS INC(SPRY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}